Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0DD8T
|
|||
Drug Name |
VERU-111
|
|||
Synonyms |
[2-(1H-indol-3-yl)-1H-imidazol-5-yl](3,4,5-trimethoxyphenyl)methanone; SCHEMBL724794; SCHEMBL20850747; CHEMBL2163631; WQGVHOVEXMOLOK-UHFFFAOYSA-N; HY-120599; CS-0078414; KUM; 1332881-26-1
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H19N3O4
|
|||
Canonical SMILES |
COC1=CC(=CC(=C1OC)OC)C(=O)C2=CN=C(N2)C3=CNC4=CC=CC=C43
|
|||
InChI |
1S/C21H19N3O4/c1-26-17-8-12(9-18(27-2)20(17)28-3)19(25)16-11-23-21(24-16)14-10-22-15-7-5-4-6-13(14)15/h4-11,22H,1-3H3,(H,23,24)
|
|||
InChIKey |
WQGVHOVEXMOLOK-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | VERU-111, an Oral, Next Generation, First-In-Class Small Molecule for the Potential Treatment of COVID-19. May 15, 2020. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.